XERS News and Press, Xeris Pharmaceuticals Inc. From 08/30/21

DUBLIN, Ireland and TREVOSE, Pa., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (Nasdaq: SBBP) (“Strongbridge”) today announced that the leading independent proxy advisory firm Institutional Shareholder Services (“ISS”) has recommended th...

Urges stockholders to vote “FOR” all transaction-related proposals at the Xeris special meeting to be held virtually on September 14, 2021 Xeris Pharmaceuticals, Inc. (Nasdaq: XERS) today announced that a leading independent proxy advisory firm Institutional Sh...

Analysts Say These Are Penny Stocks To Buy Right Now; Do You Agree? Penny stocks are well-known for their high risk. But ask any trader in 2021 and you’ll also see how many look to buy these cheap stocks for their potential rewards. Just look at the last 2 weeks, for instance. We...

Gainers: CARA +24.3%. CLXT +5.9%. ABNB +3.9%. AMTX +3.9%. ACIU +2.4%. Losers: TBPH -24.1%. XERS -3.0%. CPOP -2.7%. MRIN -2.6%. ALVR -2.1%. For further details see: CARA, CLXT, TBPH and XERS among after hours movers

Gainers: Trillium Therapeutics (NASDAQ:TRIL) +187%, Vivos Therapeutics (NASDAQ:VVOS) +57%, Xeris Pharmaceuticals (NASDAQ:XERS) +19%, ALX Oncology (NASDAQ:ALXO) +24%, Candel Therapeutics (NASDAQ:CADL) +20%. Losers: Flora Growth (NASDAQ:FLGC) -10%,&#...

Penny Stocks To Buy For Less Than A Cup Of Coffee; Are They Worth It? What are penny stocks? According to the basic Securities & Exchange Commission definition, these are stocks that can be bought for under $5 a share. When you’re talking about low prices, there are a few thi...

First ready-to-use liquid glucagon available in a single-dose vial and syringe kit for rescue Gvoke HypoPen®, Gvoke® PFS, and Gvoke® Kit – three different administration options to accommodate patients’ preferences Gvoke Kit eliminates the ...

Patents and patent applications provide additional coverage for XeriSol™ and XeriJect™ technology platforms Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize r...

Two rumored deals materialize at very large premiums. In a battle of railroads, Canadian Pacific comes back but gets rejected by Kansas City Southern. SPACs fire up with 17 new IPOs filed just last week. For further details see: Merger Arbitrage Mondays - BAMR Acquires A...

Over 240 million lives have unrestricted access 3 million Illinois Medicaid lives to be added effective Oct 1st Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize rea...